One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Many countries have approved Wegovy for weight loss in people ... trial programmes and post marketing surveillance have not ...

Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Semaglutide, a weight loss medication, did not increase the ... psychiatric safety of semaglutide and related drugs after post-marketing surveillance reports of suicidal behavior, depression ...

Taking the weight loss medication semaglutide did not increase the risk of depressive ... the psychiatric safety of ...

Here are six steps to take in order to get weight loss medication online: ...

(Photo by Jaap Arriens/NurPhoto via Getty Images) The rise of GLP-1 medications has been further fueled by substantial marketing ... Semaglutide presents a compelling option for weight loss ...

New data suggests that the benefits of Novo Nordisk’s GLP-1 agonist semaglutide in preventing cardiovascular diseases may not simply be a result of weight loss. The analysis comes from long-term ...

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or ...

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, ...

Weight-loss drugs are expensive ... the products were likely research-grade semaglutide never intended for human use. The websites used creative marketing language and imagery to imply their ...